Plasma fibrinogen: now also an antidepressant response marker?

Major depressive disorder (MDD) is one of the leading causes of global disability. It is a risk factor for noncompliance with medical treatment, with about 40% of patients not responding to currently used antidepressant drugs. The identification and clinical implementation of biomarkers that can ind...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins-de-Souza, D, Maccarrone, G, Ising, M, Kloiber, S, Lucae, S, Holsboer, F, Turck, C W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905236/
https://www.ncbi.nlm.nih.gov/pubmed/24473443
http://dx.doi.org/10.1038/tp.2013.129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905236/
https://www.ncbi.nlm.nih.gov/pubmed/24473443
http://dx.doi.org/10.1038/tp.2013.129

Ejemplares similares